Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hem3.105
PubMed Identifier: 38884042
Publication URI: http://europepmc.org/abstract/MED/38884042
Type: Journal Article/Review
Volume: 8
Parent Publication: HemaSphere
Issue: 6
ISSN: 2572-9241